Beta-catenin inhibitors in cancer immunotherapy Grant US-11946936-B2 United States of America 02 Apr 2024
Molecular biomarkers for cancer immunotherapy Grant US-11939637-B2 United States of America 26 Mar 2024
GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE… Application EP-4321866-A3 European Patent Office 20 Mar 2024
Systems and methods for predicting therapy efficacy from normalized biomarker scores Grant US-11842797-B2 United States of America 12 Dec 2023
Compositions and methods for diagnosing, evaluating and treating cancer by means of the… Grant US-11834718-B2 United States of America 05 Dec 2023
Checkpoint blockade and microsatellite instability Grant US-11753468-B2 United States of America 12 Sep 2023
Polymorphic gene typing and somatic change detection using sequencing data Grant US-11725237-B2 United States of America 15 Aug 2023
Method of reducing mesothelin-expressing tumor burden by administration of T cells… Grant US-11702472-B2 United States of America 18 Jul 2023
Systems and methods for identifying cancer treatments from normalized biomarker scores Grant US-11705220-B2 United States of America 18 Jul 2023
Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and… Grant US-11638728-B2 United States of America 02 May 2023
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-4166148-A1 European Patent Office 19 Apr 2023
Reducing beta-catenin expression to potentiate immunotherapy Grant US-11572559-B2 United States of America 07 Feb 2023
Methods for predicting responsiveness of a cancer to an immunotherapeutic agent and… Grant US-11561224-B2 United States of America 24 Jan 2023
Compositions and methods for detecting a mutant variant of a polynucleotide Grant US-11549149-B2 United States of America 10 Jan 2023
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15… Grant US-11464856-B2 United States of America 11 Oct 2022
Combination therapy with neoantigen vaccine Grant US-11452768-B2 United States of America 27 Sep 2022
Anti-cancer oncolytic virus combination therapies and elite responder selection platforms Grant US-11433108-B2 United States of America 06 Sep 2022
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-11430545-B2 United States of America 30 Aug 2022
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-11373733-B2 United States of America 28 Jun 2022
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-11367509-B2 United States of America 21 Jun 2022
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-11322226-B2 United States of America 03 May 2022
ANTI-TUMOR IMMUNITY INDUCES THE PRESENTATION OF ABERRANT PEPTIDES Application WO-2022081015-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-11302420-B2 United States of America 12 Apr 2022
Immune cell compositions and methods of use Grant US-11242375-B2 United States of America 08 Feb 2022
Using subject sequencing data and a database of therapy biomarker distributions to… Grant US-11004542-B2 United States of America 11 May 2021
Methods for profiling the t cell repertoire Grant US-10993997-B2 United States of America 04 May 2021
CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy Grant US-10983128-B2 United States of America 20 Apr 2021
Molecular biomarkers for cancer immunotherapy Grant US-10975442-B2 United States of America 13 Apr 2021
COMBINATION CANCER THERAPY AGENTS AND METHODS Application WO-2021011844-A3 World Intellectual Property Organisation (WIPO) 25 Feb 2021
Compositions and methods for diagnosing, evaluating and treating cancer Grant US-10801070-B2 United States of America 13 Oct 2020
Beta-catenin inhibitors in cancer immunotherapy Grant US-10753938-B2 United States of America 25 Aug 2020
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-3685842-A1 European Patent Office 29 Jul 2020
Method for administering a checkpoint blockade therapy to a subject Grant US-10720230-B2 United States of America 21 Jul 2020
Systems and methods for identifying responders and non-responders to immune checkpoint… Grant US-10706954-B2 United States of America 07 Jul 2020
COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE AND RESISTANCE TO CTLA4 BLOCKADE IN… Application EP-3526259-A4 European Patent Office 17 Jun 2020
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-10650911-B2 United States of America 12 May 2020
Mesothelin-targeted chimeric antigen receptors and uses thereof Grant US-10633441-B2 United States of America 28 Apr 2020
Using subject sequencing data and a database of therapy biomarker distributions to… Grant US-10636514-B2 United States of America 28 Apr 2020
Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker… Grant US-10636513-B2 United States of America 28 Apr 2020
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-10580517-B2 United States of America 03 Mar 2020
Mesothelin-targeted chimeric antigen receptors and methods of making them Grant US-10538588-B2 United States of America 21 Jan 2020
TRAF2 INHIBITORS FOR USE IN THE TREATMENT OF A CANCER Application WO-2020002592-A1 World Intellectual Property Organisation (WIPO) 02 Jan 2020
TWEAK-RECEPTOR AGONISTS FOR USE IN COMBINATION WITH IMMUNOTHERAPY OF A CANCER Application WO-2020002579-A1 World Intellectual Property Organisation (WIPO) 02 Jan 2020
Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker… Grant US-10504615-B2 United States of America 10 Dec 2019
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-10395761-B1 United States of America 27 Aug 2019
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS Application EP-3508215-A2 European Patent Office 10 Jul 2019
Systems and methods for identifying cancer treatments from normalized biomarker scores Grant US-10340030-B2 United States of America 02 Jul 2019
Systems and methods for identifying cancer treatments from normalized biomarker scores Grant US-10340031-B2 United States of America 02 Jul 2019
Systems and methods for generating, visualizing and classifying molecular functional… Grant US-10311967-B2 United States of America 04 Jun 2019
Treatment of cancer by manipulation of commensal microflora Grant US-9855302-B2 United States of America 02 Jan 2018
METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO IMMUNOTHERAPY Application WO-2017140826-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2017
GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE… Application WO-2017055612-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2017
CXCL11 AND SMICA AS PREDICTIVE BIOMARKERS FOR EFFICACY OF ANTI-CTLA4 IMMUNOTHERAPY Application WO-2016127052-A1 World Intellectual Property Organisation (WIPO) 11 Aug 2016
MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY Application WO-2016100975-A1 World Intellectual Property Organisation (WIPO) 23 Jun 2016
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application WO-2015188141-A2 World Intellectual Property Organisation (WIPO) 10 Dec 2015
IMPROVED METHODS FOR THE SELECTION OF PATIENTS FOR PD-1 OR B7-H4 TARGETED THERAPIES, AND… Application WO-2014194293-A1 World Intellectual Property Organisation (WIPO) 04 Dec 2014
BIOMARKERS FOR PREDICTING CLINICAL RESPONSE OF CANCER PATIENTS TO TREATMENT WITH… Application WO-2014078468-A3 World Intellectual Property Organisation (WIPO) 25 Sep 2014
METHODS FOR PREDICTING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS (GI-IRAE) IN… Application WO-2013138702-A2 World Intellectual Property Organisation (WIPO) 19 Sep 2013